Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Article [17P in Iowa] [3/15/2013]
Share |

Can you Compound 17-P Hydroxyprogesterone in Iowa?

Several Iowa IACP members have contacted our offices to ask about an article that appeared in the Board of Pharmacy's most recent newsletter about the compounding of 17-P.  Some have interpreted the Board's article to mean that compounding of 17-P hydroxyprogesterone is not permitted by Iowa pharmacy permit holders.  That is not correct.

In fact, at the beginning of the year, the Iowa Medicaid department issued an extensive guidance letter to providers that explained exactly how billing for Makena® or the compounded 17-P is to be handled. Click here to view the letter.

What the Board is recommending that all compounders do is document on the prescription or in other record-keeping methods the medical/clinical rationale for the use of a compounded version of a commercially available medication.  That can be done by the prescriber when the prescription is issued or by the pharmacist upon consultation with the prescriber.    And that's just a good internal practice for any pharmacist who is preparing a medication that is similar to a commercially available manufactured product.  That documentation can help answer any questions in the future if you are asked about the decision to dispense a compounded preparation rather than a commercial product.

Watch our next issue of Capitol Connections for a recap of what various states are doing with 17-P, various positions and questions raised by Boards of Pharmacy. And KV Pharmaceutical? They haven't given up trying to interrupt the practice of pharmacy.  Another appeal in their case against FDA has been filed by them as of just this week.  Click here to read the article.


 

 

 

 

 

 

 

 

 

 

 

 


 

 

Association Management Software Powered by YourMembership  ::  Legal